243 related articles for article (PubMed ID: 32109489)
1. Keep an eye on adenosine: Its role in retinal inflammation.
Santiago AR; Madeira MH; Boia R; Aires ID; Rodrigues-Neves AC; Santos PF; Ambrósio AF
Pharmacol Ther; 2020 Jun; 210():107513. PubMed ID: 32109489
[TBL] [Abstract][Full Text] [Related]
2. The Adenosinergic System in Diabetic Retinopathy.
Vindeirinho J; Santiago AR; Cavadas C; Ambrósio AF; Santos PF
J Diabetes Res; 2016; 2016():4270301. PubMed ID: 27034960
[TBL] [Abstract][Full Text] [Related]
3. Adenosine receptor expression in the adult zebrafish retina.
Grillo SL; McDevitt DS; Voas MG; Khan AS; Grillo MA; Stella SL
Purinergic Signal; 2019 Sep; 15(3):327-342. PubMed ID: 31273575
[TBL] [Abstract][Full Text] [Related]
4. Adenosine receptors: Modulators of lipid availability that are controlled by lipid levels.
Leiva A; Guzmán-Gutiérrez E; Contreras-Duarte S; Fuenzalida B; Cantin C; Carvajal L; Salsoso R; Gutiérrez J; Pardo F; Sobrevia L
Mol Aspects Med; 2017 Jun; 55():26-44. PubMed ID: 28153452
[TBL] [Abstract][Full Text] [Related]
5. Safety issues of compounds acting on adenosinergic signalling.
Schmidt J; Ferk P
J Pharm Pharmacol; 2017 Jul; 69(7):790-806. PubMed ID: 28397249
[TBL] [Abstract][Full Text] [Related]
6. Adenosine receptors and caffeine in retinopathy of prematurity.
Chen JF; Zhang S; Zhou R; Lin Z; Cai X; Lin J; Huo Y; Liu X
Mol Aspects Med; 2017 Jun; 55():118-125. PubMed ID: 28088487
[TBL] [Abstract][Full Text] [Related]
7. Adenosine transporters and receptors: key elements for retinal function and neuroprotection.
Dos Santos-Rodrigues A; Pereira MR; Brito R; de Oliveira NA; Paes-de-Carvalho R
Vitam Horm; 2015; 98():487-523. PubMed ID: 25817878
[TBL] [Abstract][Full Text] [Related]
8. The role of the adenosinergic system in lung fibrosis.
Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
[TBL] [Abstract][Full Text] [Related]
9. Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.
Beamer E; Gölöncsér F; Horváth G; Bekő K; Otrokocsi L; Koványi B; Sperlágh B
Neuropharmacology; 2016 May; 104():94-104. PubMed ID: 26384652
[TBL] [Abstract][Full Text] [Related]
10. Adenosine receptors and Huntington's disease.
Lee CF; Chern Y
Int Rev Neurobiol; 2014; 119():195-232. PubMed ID: 25175968
[TBL] [Abstract][Full Text] [Related]
11. Adenosine Receptor Reserve and Long-Term Potentiation: Unconventional Adaptive Mechanisms in Cardiovascular Diseases?
Guieu R; Brignole M; Deharo JC; Deharo P; Mottola G; Groppelli A; Paganelli F; Ruf J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299203
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of Adenosine Receptors: The State of the Art.
Borea PA; Gessi S; Merighi S; Vincenzi F; Varani K
Physiol Rev; 2018 Jul; 98(3):1591-1625. PubMed ID: 29848236
[TBL] [Abstract][Full Text] [Related]
13. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
14. Biased agonism at adenosine receptors.
McNeill SM; Baltos JA; White PJ; May LT
Cell Signal; 2021 Jun; 82():109954. PubMed ID: 33610717
[TBL] [Abstract][Full Text] [Related]
15. Adenosine receptors: new therapeutic targets for inflammation in diabetic nephropathy.
Elsherbiny NM; Al-Gayyar MM
Inflamm Allergy Drug Targets; 2013 Jun; 12(3):153-61. PubMed ID: 23621447
[TBL] [Abstract][Full Text] [Related]
16. Beneficial and detrimental role of adenosine signaling in diseases and therapy.
Liu H; Xia Y
J Appl Physiol (1985); 2015 Nov; 119(10):1173-82. PubMed ID: 26316513
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes.
Safran N; Shneyvays V; Balas N; Jacobson KA; Nawrath H; Shainberg A
Mol Cell Biochem; 2001 Jan; 217(1-2):143-52. PubMed ID: 11269659
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics?
Antonioli L; Fornai M; Colucci R; Tuccori M; Blandizzi C
Expert Opin Investig Drugs; 2011 Jun; 20(6):717-21. PubMed ID: 21506907
[No Abstract] [Full Text] [Related]
19. Adenosine signaling and the immune system: When a lot could be too much.
Antonioli L; Fornai M; Blandizzi C; Pacher P; Haskó G
Immunol Lett; 2019 Jan; 205():9-15. PubMed ID: 29702147
[TBL] [Abstract][Full Text] [Related]
20. Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.
Antonioli L; Blandizzi C; Csóka B; Pacher P; Haskó G
Nat Rev Endocrinol; 2015 Apr; 11(4):228-41. PubMed ID: 25687993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
